Samrat Pharmachem Ltd
BSE:530125
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samrat Pharmachem Ltd
BSE:530125
|
IN |
|
Wagners Holding Company Ltd
ASX:WGN
|
AU |
|
Schindler Holding AG
LSE:0QOT
|
CH |
|
BioMarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
Dividends
Dividend Yield
Samrat Pharmachem Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Samrat Pharmachem Ltd
SAMRATPH have decreased by 0%.
Payout Ratio
Samrat Pharmachem Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for SAMRATPH is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
SAMRATPH Price
Samrat Pharmachem Ltd
| Average Annual Return | 6.66% |
| Standard Deviation of Annual Returns | 67.05% |
| Max Drawdown | -84% |
| Market Capitalization | 715.3m INR |
| Shares Outstanding | 3 090 000 |
| Percentage of Shares Shorted |
N/A
|
